33
https://pubmed.ncbi.nlm.nih.gov/38114366
The PreciseDx digital breast cancer test for predicting early-stage recurrence shows robustness and reproducibility in its analytical validation.
https://pubmed.ncbi.nlm.nih.gov/38114366
The PreciseDx digital breast cancer test for predicting early-stage recurrence shows robustness and reproducibility in its analytical validation.